Serum Isthmin-1 Was Increased in Type 2 Diabetic Patients but Not in Diabetic Sensorimotor Peripheral Neuropathy

References

• Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. doi:10.1038/nrendo.2017.151
   PubMed Web of Science ®Google Scholar
• Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol. 2022;18(9):525–539. doi:10.1038/s41574-022-00690-7
   PubMed Web of Science ®Google Scholar
• Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol. 2021;17(7):400–420. doi:10.1038/s41574-021-00496-z
   PubMed Web of Science ®Google Scholar
• Ziegler D, Tesfaye S, Spallone V, et al. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: international expert consensus recommendations. Diabetes Res Clin Pract. 2022;186:109063. doi:10.1016/j.diabres.2021.109063
   PubMed Web of Science ®Google Scholar
• Longo M, Zatterale F, Naderi J, et al. Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci. 2019;20(9):2358. doi:10.3390/ijms20092358
   PubMed Web of Science ®Google Scholar
• Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021;9(6):373–392. doi:10.1016/S2213-8587(21)00045-0
   PubMed Web of Science ®Google Scholar
• Zhang M, Hu T, Zhang S, et al. Associations of different adipose tissue depots with insulin resistance: a systematic review and meta-analysis of observational studies. Sci Rep. 2015;5(1):18495. doi:10.1038/srep18495
   PubMedGoogle Scholar
• Fasshauer M, Bluher M. Adipokines in health and disease. Trends Pharmacol Sci. 2015;36(7):461–470. doi:10.1016/j.tips.2015.04.014
   PubMed Web of Science ®Google Scholar
• Wang K, Li F, Wang C, et al. Serum Levels of Meteorin-Like (Metrnl) are increased in patients with newly diagnosed type 2 diabetes mellitus and are associated with insulin resistance. Med Sci Monit. 2019;25:2337–2343. doi:10.12659/MSM.915331
   PubMed Web of Science ®Google Scholar
• Du Y, Ye X, Lu A, et al. Inverse relationship between serum Metrnl levels and visceral fat obesity (VFO) in patients with type 2 diabetes. Diabetes Res Clin Pract. 2020;161:108068. doi:10.1016/j.diabres.2020.108068
   PubMed Web of Science ®Google Scholar
• Sun Q, Yan B, Yang D, et al. Serum adiponectin levels are positively associated with diabetic peripheral neuropathy in Chinese Patients with type 2 diabetes. Front Endocrinol. 2020;11:567959. doi:10.3389/fendo.2020.567959
   PubMed Web of Science ®Google Scholar
• Pera EM, Kim JI, Martinez SL, et al. Isthmin is a novel secreted protein expressed as part of the Fgf-8 synexpression group in the Xenopus midbrain-hindbrain organizer. Mech Dev. 2002;116(1–2):169–172. doi:10.1016/s0925-4773(02)00123-5
   PubMed Web of Science ®Google Scholar
• Valle-Rios R, Maravillas-Montero JL, Burkhardt AM, et al. Isthmin 1 is a secreted protein expressed in skin, mucosal tissues, and NK, NKT, and Th17 cells. J Interf Cytokine Res. 2014;34(10):795–801. doi:10.1089/jir.2013.0137
   PubMed Web of Science ®Google Scholar
• Osorio L, Wu X, Zhou Z. Distinct spatiotemporal expression of ISM1 during mouse and chick development. Cell Cycle. 2014;13(10):1571–1582. doi:10.4161/cc.28494
   PubMed Web of Science ®Google Scholar
• Jiang Z, Zhao M, Voilquin L, et al. Isthmin-1 is an adipokine that promotes glucose uptake and improves glucose tolerance and steatosis. Cell Metab. 2021;33(9):1836–1852. doi:10.1016/j.cmet.2021.07.010
   PubMed Web of Science ®Google Scholar
• Nguyen N, Xu S, Lam TYW, et al. ISM1 suppresses LPS-induced acute lung injury and post-injury lung fibrosis in mice. Mol Med. 2022;28(1):72–89. doi:10.1186/s10020-022-00500-w
   PubMed Web of Science ®Google Scholar
• Duman TT, Aktas G, Atak BM, et al. Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus. Afr Health Sci. 2019;19(1):1602–1606. doi:10.4314/ahs.v19i1.35
   PubMed Web of Science ®Google Scholar
• Aktas G, Alcelik A, Ozlu T, et al. Association between omentin levels and insulin resistance in pregnancy. Exp Clin Endocrinol Diabetes. 2014;122(3):163–166. doi:10.1055/s-0034-1370917
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Erkus E, et al. Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitus. Swiss Med Wkly. 2019;149:w20139. doi:10.4414/smw.2019.20139
   PubMed Web of Science ®Google Scholar
• Akan S, Aktas G. Relationship between frailty, according to three frail scores, and clinical and laboratory parameters of the geriatric patients with type 2 Diabetes Mellitus. Rev Assoc Med Bras. 2022;68(8):1073–1077. doi:10.1590/1806-9282.20220271
   PubMed Web of Science ®Google Scholar
• Erkus E, Aktas G, Kocak MZ, et al. Diabetic regulation of subjects with type 2 diabetes mellitus is associated with serum vitamin D levels. Rev Assoc Med Bras. 2019;65(1):51–55. doi:10.1590/1806-9282.65.1.51
   PubMed Web of Science ®Google Scholar
• Aktas G, Kocak MZ, Bilgin S, et al. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male. 2020;23(5):1098–1102. doi:10.1080/13685538.2019.1678126
   PubMed Web of Science ®Google Scholar
• Bilgin S, Kurtkulagi O, Atak Tel BM, et al. Does C-reactive protein to serum Albumin Ratio correlate with diabEtic nephropathy in patients with type 2 dIabetes MEllitus? The CARE TIME study. Prim Care Diabetes. 2021;15(6):1071–1074. doi:10.1016/j.pcd.2021.08.015
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Atak BM, et al. Is Neuregulin-4 a predictive marker of microvascular complications in type 2 diabetes mellitus? Eur J Clin Invest. 2020;50(3):e13206. doi:10.1111/eci.13206
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Duman TT, et al. Monocyte lymphocyte ratio as a predictor of diabetic kidney injury in type 2 diabetes mellitus; the MADKID study. J Diabetes Metab Disord. 2020;19(2):997–1002. doi:10.1007/s40200-020-00595-0
   PubMed Web of Science ®Google Scholar
• Tekce H, Tekce BK, Aktas G, et al. Serum omentin-1 levels in diabetic and nondiabetic patients with chronic kidney disease. Exp Clin Endocrinol Diabetes. 2014;122(8):451–456. doi:10.1055/s-0034-1375674
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Erkus E, et al. Mean platelet volume to lymphocyte ratio as a novel marker for diabetic nephropathy. J Coll Physicians Surg Pak. 2018;28(11):844–847. doi:10.29271/jcpsp.2018.11.844
   PubMed Web of Science ®Google Scholar
• Kin Tekce B, Tekce H, Aktas G, et al. Evaluation of the urinary kidney injury molecule-1 levels in patients with diabetic nephropathy. Clin Invest Med. 2014;37(6):E377–E383. doi:10.25011/cim.v37i6.22242
   PubMed Web of Science ®Google Scholar
• Wang J, Du J, Ge X, et al. Circulating Ism1 reduces the risk of type 2 diabetes but not diabetes-associated NAFLD. Front Endocrinol. 2022;13:890332–890339. doi:10.3389/fendo.2022.890332
   PubMedGoogle Scholar
• Wang C, Xu M, Feng R, et al. Serum isthmin-1 levels are positively and independently correlated with albuminuria in patients with type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2022;10(5):e002972–e002979. doi:10.1136/bmjdrc-2022-002972
   PubMed Web of Science ®Google Scholar
• Ruiz-Ojeda FJ, Anguita-Ruiz A, Rico MC, et al. Serum levels of the novel adipokine isthmin-1 are associated with obesity in pubertal boys. World J Pediatr. 2023. doi:10.1007/s12519-022-00665-8
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553. doi:10.1002/(SICI)1096-9136(199807)15:7
   PubMed Web of Science ®Google Scholar
• Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285–2293. doi:10.2337/dc10-1303
   PubMed Web of Science ®Google Scholar
• Matsushita K, Mahmoodi BK, Woodward M, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA. 2012;307(18):1941–1951. doi:10.1001/jama.2012.3954
   PubMed Web of Science ®Google Scholar
• Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–1495. doi:10.2337/diacare.27.6.1487
   PubMed Web of Science ®Google Scholar
• Jaiswal M, Divers J, Dabelea D, et al. Prevalence of and risk factors for diabetic peripheral neuropathy in youth with type 1 and type 2 diabetes: SEARCH for diabetes in youth study. Diabetes Care. 2017;40(9):1226–1232. doi:10.2337/dc17-0179
   PubMed Web of Science ®Google Scholar
• Ziegler D, Papanas N, Vinik AI, et al. Epidemiology of polyneuropathy in diabetes and prediabetes. Handb Clin Neurol. 2014;126:3–22. doi:10.1016/B978-0-444-53480-4.00001-1
   PubMedGoogle Scholar
• Pereira S, Cline DL, Glavas MM, et al. Tissue-specific effects of leptin on glucose and lipid metabolism. Endocr Rev. 2021;42(1):1–28. doi:10.1210/endrev/bnaa027
   PubMed Web of Science ®Google Scholar
• Dunmore SJ, Brown JE. The role of adipokines in β-cell failure of type 2 diabetes. J Endocrinol. 2013;216(1):T37–T45. doi:10.1530/JOE-12-0278
   PubMed Web of Science ®Google Scholar
• Banks WA. The blood-brain barrier as an endocrine tissue. Nat Rev Endocrinol. 2019;15(8):444–455. doi:10.1038/s41574-019-0213-7
   PubMed Web of Science ®Google Scholar
• Osorio L, Wu X, Wang L, et al. ISM1 regulates NODAL signaling and asymmetric organ morphogenesis during development. J Cell Biol. 2019;218(7):2388–2402. doi:10.1083/jcb.201801081
   PubMed Web of Science ®Google Scholar
• Boerner BP, George NM, Targy NM, et al. TGF-β superfamily member nodal stimulates human β-cell proliferation while maintaining cellular viability. Endocrinology. 2013;154(11):4099–4112. doi:10.1210/en.2013-1197
   PubMed Web of Science ®Google Scholar
• Wu Y, Liang X, Ni J, et al. Effect of ISM1 on the immune microenvironment and epithelial-mesenchymal transition in colorectal cancer. Front Cell Dev Biol. 2021;9:681240. doi:10.3389/fcell.2021.681240
   PubMedGoogle Scholar
• Zhao F, Huang F, Tang M, et al. Nodal induces apoptosis through activation of the ALK7 signaling pathway in pancreatic INS-1 beta-cells. Am J Physiol Endocrinol Metab. 2012;303(1):E132–E143. doi:10.1152/ajpendo.00074.2012
   PubMed Web of Science ®Google Scholar
• Steiner BM, Berry DC. The regulation of adipose tissue health by estrogens. Front Endocrinol. 2022;13:889923. doi:10.3389/fendo.2022.889923
   PubMedGoogle Scholar
• Delaney KZ, Santosa S. Sex differences in regional adipose tissue depots pose different threats for the development of Type 2 diabetes in males and females. Obes Rev. 2022;23(3):e13393. doi:10.1111/obr.13393
   PubMed Web of Science ®Google Scholar
• Lam TYW, Nguyen N, Peh HY, et al. ISM1 protects lung homeostasis via cell-surface GRP78-mediated alveolar macrophage apoptosis. Proc Natl Acad Sci U S A. 2022;119(4):e2019161119.
   PubMed Web of Science ®Google Scholar
• Schmitt M, Greten FR. The inflammatory pathogenesis of colorectal cancer. Nat Rev Immunol. 2021;21(10):653–667. doi:10.1038/s41577-021-00534-x
   PubMed Web of Science ®Google Scholar
• Lockhart JS, Sumagin R. Non-canonical functions of myeloperoxidase in immune regulation, tissue inflammation and cancer. Int J Mol Sci. 2022;23(20):12250–12267. doi:10.3390/ijms232012250
   PubMed Web of Science ®Google Scholar
• Xiang W, Ke Z, Zhang Y, et al. Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumour growth in mice. J Cell Mol Med. 2011;15(2):359–374. doi:10.1111/j.1582-4934.2009.00961.x
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen M, Venugopal S, et al. Isthmin exerts pro-survival and death-promoting effect on endothelial cells through alphavbeta5 integrin depending on its physical state. Cell Death Dis. 2011:2e153. doi:10.1038/cddis.2011.37
   Web of Science ®Google Scholar
• Chen M, Zhang Y, Yu VC, et al. Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction. Cell Death Differ. 2014;21(5):797–810. doi:10.1038/cdd.2014.3
   PubMed Web of Science ®Google Scholar
• Li J, Xia Y, Huang Z, et al. Novel HIF-1-target gene isthmin1 contributes to hypoxia-induced hyperpermeability of pulmonary microvascular endothelial cells monolayers. Am J Physiol Cell Physiol. 2021;321(4):C671–C680. doi:10.1152/ajpcell.00124.2021
   PubMed Web of Science ®Google Scholar
• Iacobini C, Vitale M, Haxhi J, et al. Mutual regulation between redox and hypoxia-inducible factors in cardiovascular and renal complications of diabetes. Antioxidants. 2022;11(11). doi:10.3390/antiox11112183
   Web of Science ®Google Scholar
• Li C, Song L, Zhou Y, et al. Identification of Isthmin1 in the small annual fish, Nothobranchius guentheri, as a novel biomarker of aging and its potential rejuvenation activity. Biogerontology. 2022;23(1):99–114. doi:10.1007/s10522-021-09948-5
   PubMed Web of Science ®Google Scholar
• Zheng Y, Zheng Y, Lei W, et al. miR-1307-3p overexpression inhibits cell proliferation and promotes cell apoptosis by targeting ISM1 in colon cancer. Mol Cell Probes. 2019:48101445. doi:10.1016/j.mcp.2019.101445
   Web of Science ®Google Scholar
• Jang J, Jung Y, Chae S, et al. WNT/beta-catenin pathway modulates the TNF-alpha-induced inflammatory response in bronchial epithelial cells. Biochem Biophys Res Commun. 2017;484(2):442–449. doi:10.1016/j.bbrc.2017.01.156
   PubMed Web of Science ®Google Scholar
• Cheng X, Xu X, Chen D, et al. Therapeutic potential of targeting the Wnt/beta-catenin signaling pathway in colorectal cancer. Biomed Pharmacother. 2019;110:473–481. doi:10.1016/j.biopha.2018.11.082
   PubMed Web of Science ®Google Scholar
• Wang YG, Wang T, Ding M, et al. hsa_circ_0091570 acts as a ceRNA to suppress hepatocellular cancer progression by sponging hsa-miR-1307. Cancer Lett. 2019;460:128–138. doi:10.1016/j.canlet.2019.06.007
   PubMed Web of Science ®Google Scholar
• Li X, Liu R, Wang Y, et al. Cholangiocyte-derived exosomal lncRNA H19 promotes macrophage activation and hepatic inflammation under cholestatic conditions. Cells. 2020;9(1):190. doi:10.3390/cells9010190
   PubMed Web of Science ®Google Scholar
• Li H, Yu B, Li J, et al. Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget. 2014;5(8):2318–2329. doi:10.18632/oncotarget.1913
   PubMedGoogle Scholar
• Cole JB, Florez JC. Genetics of diabetes mellitus and diabetes complications. Nat Rev Nephrol. 2020;16(7):377–390. doi:10.1038/s41581-020-0278-5
   PubMed Web of Science ®Google Scholar
• Yao Y, Song Q, Hu C, et al. Endothelial cell metabolic memory causes cardiovascular dysfunction in diabetes. Cardiovasc Res. 2022;118(1):196–211. doi:10.1093/cvr/cvab013
   PubMed Web of Science ®Google Scholar
• Dillmann WH. Diabetic cardiomyopathy. Circ Res. 2019;124(8):1160–1162. doi:10.1161/CIRCRESAHA.118.314665
   PubMed Web of Science ®Google Scholar
• Pitt B, Filippatos G, Agarwal R, et al. Cardiovascular events with finerenone in kidney disease and type 2 diabetes. N Engl J Med. 2021;385(24):2252–2263. doi:10.1056/NEJMoa2110956
   PubMed Web of Science ®Google Scholar